Abstract Volume:4 Issue-7 Year-2016 Original Research Articles
Online ISSN : 2347 - 3215 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcret@gmail.com |
2Department of Chemistry, Pushpagiri College of Pharmacy, Thiruvalla-689107, Kerala, India
3HOD of Cardiology, Pushpagiri Medical College, Thiruvalla, 689107, Kerala, India
4Department of Pharmacy Practice, Pushpagiri College of Pharmacy, Thiruvalla-689107, Kerala, India
Cardiovascular diseases are common and costly medical condition. Nowadays, combination of angiotensin receptor blockers (ARB) with aldosterone receptor blocker is used to treat patients with heart failure or hypertension. Angiotensin II receptor blockers (ARBs) are an alternative for patients who cannot tolerate angiotensin converting enzyme inhibitors because of their cost and side effects (e.g., cough). Unfortunately these drugs may lead to increase in morbidity and mortality dependent on severe hyperkalemia. The review aims to evaluate the therapeutics and demographic features of patients with hyperkalemia. These cases revealed, close monitoring of blood chemistry is mandatory after starting spironolactone.CHF patients taking angiotensin receptor blocker and spironolactone were taken and their effect of serum potassium were considered.
How to cite this article:
Mathew George, Lincy Joseph, K.Venugopal and Aneeta Anna Abraham. 2016. Evaluation of Rise in Creatinine in Concomitant Use of Angiotensin Receptor Blockers and Mineralocortioid Receptor Antagonist.Int.J.Curr.Res.Aca.Rev. 4(7): 38-43doi: http://dx.doi.org/10.20546/ijcrar.2016.407.005
Quick Navigation
- Print Article
- Full Text PDF
- How to Cite this Article
- on Google
- on Google Scholor
- Citation Alert By Google Scholar